{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:12:44Z","timestamp":1791180764080,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00125-009-1309-8","type":"journal-article","created":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T16:58:13Z","timestamp":1236617893000},"page":"972-981","source":"Crossref","is-referenced-by-count":50,"title":["Inhibition of the chemokine (C\u2013C motif) ligand 2\/chemokine (C\u2013C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy"],"prefix":"10.1007","volume":"52","author":[{"given":"S. J.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. B.","family":"IglayReger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Kadouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. F.","family":"Bodary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"1309_CR1","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202\u20131219","journal-title":"Hepatology"},{"key":"1309_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","volume":"14","author":"RS Rector","year":"2008","unstructured":"Rector RS, Thyfault JP, Wei Y, Ibdah JA (2008) Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14:185\u2013192","journal-title":"World J Gastroenterol"},{"key":"1309_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1566524053766031","volume":"5","author":"H Yki-Jarvinen","year":"2005","unstructured":"Yki-Jarvinen H, Westerbacka J (2005) The fatty liver and insulin resistance. Curr Mol Med 5:287\u2013295","journal-title":"Curr Mol Med"},{"key":"1309_CR4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","volume":"12","author":"IR Wanless","year":"1990","unstructured":"Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106\u20131110","journal-title":"Hepatology"},{"key":"1309_CR5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-133-4-200008150-00017","volume":"133","author":"OP Ganda","year":"2000","unstructured":"Ganda OP (2000) Lipoatrophy, lipodystrophy, and insulin resistance. Ann Intern Med 133:304\u2013306","journal-title":"Ann Intern Med"},{"key":"1309_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","volume":"413","author":"M Seip","year":"1996","unstructured":"Seip M, Trygstad O (1996) Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 413:2\u201328","journal-title":"Acta Paediatr Suppl"},{"key":"1309_CR7","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","volume":"275","author":"JK Kim","year":"2000","unstructured":"Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI (2000) Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice. J Biol Chem 275:8456\u20138460","journal-title":"J Biol Chem"},{"key":"1309_CR8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793\u20131801","journal-title":"J Clin Invest"},{"key":"1309_CR9","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796\u20131808","journal-title":"J Clin Invest"},{"key":"1309_CR10","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821\u20131830","journal-title":"J Clin Invest"},{"key":"1309_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1463-1326.2004.00439.x","volume":"7","author":"M Krebs","year":"2005","unstructured":"Krebs M, Roden M (2005) Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab 7:621\u2013632","journal-title":"Diabetes Obes Metab"},{"key":"1309_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MCO.0b013e328042ba90","volume":"10","author":"J Delarue","year":"2007","unstructured":"Delarue J, Magnan C (2007) Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10:142\u2013148","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1309_CR13","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.2337\/diabetes.54.12.3458","volume":"54","author":"G Boden","year":"2005","unstructured":"Boden G, She P, Mozzoli M et al (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54:3458\u20133465","journal-title":"Diabetes"},{"key":"1309_CR14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Damas JK, Konopski Z et al (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44:1167\u20131174","journal-title":"J Hepatol"},{"key":"1309_CR15","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","volume":"56","author":"J Westerbacka","year":"2007","unstructured":"Westerbacka J, Kolak M, Kiviluoto T et al (2007) Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56:2759\u20132765","journal-title":"Diabetes"},{"key":"1309_CR16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","volume":"116","author":"H Kanda","year":"2006","unstructured":"Kanda H, Tateya S, Tamori Y et al (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494\u20131505","journal-title":"J Clin Invest"},{"key":"1309_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","volume":"116","author":"SP Weisberg","year":"2006","unstructured":"Weisberg SP, Hunter D, Huber R et al (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116:115\u2013124","journal-title":"J Clin Invest"},{"key":"1309_CR18","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","volume":"12","author":"J Moitra","year":"1998","unstructured":"Moitra J, Mason MM, Olive M et al (1998) Life without white fat: a transgenic mouse. Genes Dev 12:3168\u20133181","journal-title":"Genes Dev"},{"key":"1309_CR19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772\u2013783","journal-title":"Nat Rev Immunol"},{"key":"1309_CR20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911\u2013919","journal-title":"J Allergy Clin Immunol"},{"key":"1309_CR21","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2337\/db07-0111","volume":"56","author":"M Kolak","year":"2007","unstructured":"Kolak M, Westerbacka J, Velagapudi VR et al (2007) Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56:1960\u20131968","journal-title":"Diabetes"},{"key":"1309_CR22","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1210\/jc.2005-0369","volume":"90","author":"I Dahlman","year":"2005","unstructured":"Dahlman I, Kaaman M, Olsson T et al (2005) A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 90:5834\u20135840","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.ijo.0803259","volume":"30","author":"CS Kim","year":"2006","unstructured":"Kim CS, Park HS, Kawada T et al (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J obesity 30:1347\u20131355","journal-title":"Int J obesity"},{"key":"1309_CR24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00125-006-0190-y","volume":"49","author":"C Herder","year":"2006","unstructured":"Herder C, Baumert J, Thorand B et al (2006) Chemokines as risk factors for type 2 diabetes: results from the MONICA\/KORA Augsburg study, 1984\u20132002. Diabetologia 49:921\u2013929","journal-title":"Diabetologia"},{"key":"1309_CR25","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.2337\/diabetes.50.10.2384","volume":"50","author":"JI Barzilay","year":"2001","unstructured":"Barzilay JI, Abraham L, Heckbert SR et al (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384\u20132389","journal-title":"Diabetes"},{"key":"1309_CR26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabres.2006.07.001","volume":"75","author":"H Chen","year":"2007","unstructured":"Chen H, Ren A, Hu S, Mo W, Xin X, Jia W (2007) The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Res Clin Pract 75:327\u2013332","journal-title":"Diabetes Res Clin Pract"},{"key":"1309_CR27","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.2337\/db07-0425","volume":"56","author":"KE Inouye","year":"2007","unstructured":"Inouye KE, Shi H, Howard JK et al (2007) Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56:2242\u20132250","journal-title":"Diabetes"},{"key":"1309_CR28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/ATVBAHA.108.168633","volume":"28","author":"Y Tamura","year":"2008","unstructured":"Tamura Y, Sugimoto M, Murayama T et al (2008) Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db\/db mice. Arterioscler Thromb Vasc Biol 28:2195\u20132201","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1309_CR29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","volume":"48","author":"K Wouters","year":"2008","unstructured":"Wouters K, van Gorp PJ, Bieghs V et al (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474\u2013486","journal-title":"Hepatology"},{"key":"1309_CR30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1097\/01.ASN.0000089563.63641.A8","volume":"14","author":"K Furuichi","year":"2003","unstructured":"Furuichi K, Wada T, Iwata Y et al (2003) CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14:2503\u20132515","journal-title":"J Am Soc Nephrol"},{"key":"1309_CR31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)63292-0","volume":"165","author":"K Kitagawa","year":"2004","unstructured":"Kitagawa K, Wada T, Furuichi K et al (2004) Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165:237\u2013246","journal-title":"Am J Pathol"},{"key":"1309_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-7643-7437-2_9","volume-title":"Chemokine biology\u2014basic research and clinical application","author":"P Higgins","year":"2007","unstructured":"Higgins P, Schwartz E, Nicolas J (2007) Small molecule CCR2 antagonists. In: Neote K, Letts G, Moser B (eds) Chemokine biology\u2014basic research and clinical application. Birkhauser, Basel, pp 115\u2013123"},{"key":"1309_CR33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2007.06.148","volume":"360","author":"H Kanamori","year":"2007","unstructured":"Kanamori H, Matsubara T, Mima A et al (2007) Inhibition of MCP-1\/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun 360:772\u2013777","journal-title":"Biochem Biophys Res Commun"},{"key":"1309_CR34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1053\/jhep.2002.33162","volume":"35","author":"DM Dambach","year":"2002","unstructured":"Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL (2002) Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093\u20131103","journal-title":"Hepatology"},{"key":"1309_CR35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.174.3.1549","volume":"174","author":"KL Hokeness","year":"2005","unstructured":"Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP (2005) Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha\/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 174:1549\u20131556","journal-title":"J Immunol"},{"key":"1309_CR36","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1381\/096089206778663715","volume":"16","author":"J Arun","year":"2006","unstructured":"Arun J, Clements RH, Lazenby AJ, Leeth RR, Abrams GA (2006) The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg 16:1351\u20131358","journal-title":"Obes Surg"},{"key":"1309_CR37","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","volume":"325","author":"BW Walsh","year":"1991","unstructured":"Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196\u20131204","journal-title":"N Engl J Med"},{"key":"1309_CR38","first-page":"G107","volume":"268","author":"S Grimbert","year":"1995","unstructured":"Grimbert S, Fisch C, Deschamps D et al (1995) Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy. Am J Physiol 268:G107\u2013G115","journal-title":"Am J Physiol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1309-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-009-1309-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1309-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:47:10Z","timestamp":1558612030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-009-1309-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1007\/s00125-009-1309-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,10]]}}}